Ivabradine Reduces Chemokine-Induced CD4-Positive Lymphocyte Migration
Aims. Migration of CD4-positive lymphocytes into the vessel wall is a critical step in atherogenesis. Recent data suggest that ivabradine, a selective I(f)-channel blocker, reduces atherosclerotic plaque formation in apolipoprotein E-deficient mice, hitherto nothing is known about the mechanism by w...
Saved in:
| Main Authors: | Thomas Walcher, Peter Bernhardt, Dusica Vasic, Helga Bach, Renate Durst, Wolfgang Rottbauer, Daniel Walcher |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2010/751313 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An overview of ivabradine
by: Tumelo Ramoleta, et al.
Published: (2016-12-01) -
Erratum to “Are Nuclear Star Clusters the Precursors of Massive Black Holes?”
by: Nadine Neumayer, et al.
Published: (2012-01-01) -
WSX-1 signalling inhibits CD4⁺ T cell migration to the liver during malaria infection by repressing chemokine-independent pathways.
by: Ana Villegas-Mendez, et al.
Published: (2013-01-01) -
GENE POLYMORPHISM ANALYSIS OF CHEMOKINES, CHEMOKINE RECEPTORS, ACUTE PHASE PROTEINS, AND CD14 IN FEMALE OBESITY DEVELOPMENT
by: O. V. Kochetova, et al.
Published: (2018-11-01) -
Heart rate-reducing agents ivabradine and beta-adrenoblockers in the management of patients with stable effort angina
by: Z. M. Galeeva, et al.
Published: (2011-02-01)